Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Karyopharm Therapeutics Inc.(KPTI US)

$0.83+0.3573.35%Ext:$0.80-0.044.44%(After Hours · 23:25:17 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
KPTI US​
Ask AI

SEC Filings

Financials(54)

Expand
  • 10-QQ2ended 30 Jun 202613 Aug
  • 10-QQ1ended 31 Mar 202614 May
  • 10-KFY 2025ended 31 Dec 202512 Feb
  • 10-QQ3ended 30 Sept 20253 Nov 2025
  • 10-QQ2ended 30 Jun 202511 Aug 2025
  • 10-QQ1ended 31 Mar 202512 May 2025
  • 10-KFY 2024ended 31 Dec 202419 Feb 2025
  • 10-QQ3ended 30 Sept 20245 Nov 2024
  • 10-QQ2ended 30 Jun 20246 Aug 2024
  • 10-QQ1ended 31 Mar 20248 May 2024
  • 10-QQ3ended 30 Sept 20232 Nov 2023
  • 10-QQ2ended 30 Jun 20232 Aug 2023
  • 10-QQ1ended 31 Mar 20234 May 2023
  • 10-KFY 2022ended 31 Dec 202217 Feb 2023
  • 10-QQ3ended 30 Sept 20223 Nov 2022

Events(193)

Expand
  • 8-KOther Events22 Oct
  • 8-KOther Events14 Oct
  • 8-KMaterial Modifications to Rights of Security Holders18 Sep
  • 8-KEntry into a Material Definitive Agreement11 Sep
  • 8-KOther Events31 Aug
  • 8-KResults of Operations and Financial Condition13 Aug
  • 8-KOther Events31 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers17 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers28 May
  • 8-KResults of Operations and Financial Condition14 May
  • 8-KOther Events27 Mar
  • 8-KBELIEVERS IN THE EXTRAORDINARY24 Mar
  • 8-KEntry into a Material Definitive Agreement2 Mar
  • 8-KSubmission of Matters to a Vote of Security Holders19 Feb
  • 8-KResults of Operations and Financial Condition12 Feb

Insider Ownership(601)

Expand
  • 4Statement of changes in beneficial ownership19 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Sep
  • 4Statement of changes in beneficial ownership30 Jul
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership26 May
  • 4Statement of changes in beneficial ownership15 May
  • 4Statement of changes in beneficial ownership15 May
  • 4Statement of changes in beneficial ownership15 May
  • 4Statement of changes in beneficial ownership15 May
  • 4Statement of changes in beneficial ownership15 May

Beneficial Ownership(138)

Expand
  • SC 13G/AKaryopharm Therapeutics Inc.05:34PM
  • SC 13G/AKaryopharm Therapeutics Inc.8 Oct
  • SC 13G/AKaryopharm Therapeutics Inc.25 Sep
  • SC 13G/AKaryopharm Therapeutics Inc.25 Sep
  • SC 13GKaryopharm Therapeutics Inc.4 Sep
  • SC 13G/AKaryopharm Therapeutics Inc.14 Aug
  • SC 13G/AKaryopharm Therapeutics Inc.14 Aug
  • SC 13G/AKaryopharm Therapeutics Inc.12 Aug
  • SC 13G/AKaryopharm Therapeutics Inc.11 Aug
  • SC 13GKaryopharm Therapeutics Inc.28 Jul
  • SC 13G/AKaryopharm Therapeutics Inc.5 Jun
  • SC 13GKaryopharm Therapeutics Inc.15 May
  • SC 13GKaryopharm Therapeutics Inc.15 May
  • SC 13G/AKaryopharm Therapeutics Inc.14 May
  • SC 13GKaryopharm Therapeutics Inc.13 May

Other Ownership(1)

Expand
  • 144Notice of proposed sale of securities23 Jul 2014

Proxies(39)

Expand
  • ARSAnnual report to security holders13 Apr
  • DEF 14ADefinitive proxy statement13 Apr
  • DEF 14ADefinitive proxy statement9 Jan
  • PRE 14APreliminary proxy statement30 Dec 2025
  • DEF 14ADefinitive proxy statement14 Apr 2025
  • ARSAnnual report to security holders14 Apr 2025
  • DEFA14ADefinitive additional materials14 Apr 2025
  • DEF 14ADefinitive proxy statement16 Dec 2024
  • PRE 14APreliminary proxy statement5 Dec 2024
  • ARSAnnual report to security holders19 Apr 2024
  • DEF 14ADefinitive proxy statement19 Apr 2024
  • DEFA14ADefinitive additional materials19 Apr 2024
  • PRE 14APreliminary proxy statement8 Apr 2024
  • ARSAnnual report to security holders11 Apr 2023
  • DEF 14ADefinitive proxy statement11 Apr 2023

Registrations(68)

Expand
  • S-8Registration statement (employee benefit plan)27 May
  • S-8Registration statement (employee benefit plan)27 May
  • S-3Registration statement (primary offering)4 May
  • S-3Registration statement (primary offering)4 May
  • 424B3Prospectus filing (Rule 424(b)(3))24 Nov 2025
  • 424B3Prospectus filing (Rule 424(b)(3))24 Nov 2025
  • S-3Registration statement (primary offering)3 Nov 2025
  • S-3Registration statement (primary offering)3 Nov 2025
  • S-8Registration statement (employee benefit plan)11 Aug 2025
  • S-8Registration statement (employee benefit plan)5 Nov 2024
  • S-3Registration statement (primary offering)30 May 2024
  • S-8Registration statement (employee benefit plan)30 May 2024
  • S-8Registration statement (employee benefit plan)2 Aug 2023
  • S-3Registration statement (primary offering)17 Feb 2023
  • S-8Registration statement (employee benefit plan)17 Feb 2023

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence12 May
  • CORRESPFiling review correspondence12 May
  • CORRESPFiling review correspondence5 Jun 2024
  • CORRESPFiling review correspondence3 Apr 2024
  • CORRESPFiling review correspondence3 May 2023
  • CORRESPFiling review correspondence29 Dec 2022
  • CORRESPFiling review correspondence22 Apr 2019
  • CORRESPFiling review correspondence13 Feb 2018
  • CORRESPFiling review correspondence13 Feb 2018
  • CORRESPFiling review correspondence29 Nov 2016
  • CORRESPFiling review correspondence2 May 2016

SEC Orders And Notices(18)

Expand
  • EFFECTNotice of effectiveness15 May
  • EFFECTNotice of effectiveness15 May
  • EFFECTNotice of effectiveness7 Jun 2024
  • EFFECTNotice of effectiveness5 May 2023
  • EFFECTNotice of effectiveness3 Jan 2023
  • CT ORDERConfidential treatment order13 Jul 2021
  • CT ORDERConfidential treatment order19 Apr 2021
  • EFFECTNotice of effectiveness24 Apr 2019
  • CT ORDERConfidential treatment order20 Aug 2018
  • CT ORDERConfidential treatment order14 Jun 2018
  • CT ORDERConfidential treatment order5 Apr 2018
  • EFFECTNotice of effectiveness14 Feb 2018
  • EFFECTNotice of effectiveness1 Dec 2016
  • CT ORDERConfidential treatment order26 Sep 2016
  • EFFECTNotice of effectiveness17 May 2016

Tender Offers And Going Private(3)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)19 Jul 2024
  • SC TO-ITender offer statement (issuer)20 Jun 2024
  • SC TO-CTender offer statement (communication)8 Apr 2024

Exempt Offerings(4)

Expand
  • DNotice of exempt offering of securities (Reg D)1 Aug 2013
  • DNotice of exempt offering of securities (Reg D)1 May 2013
  • DNotice of exempt offering of securities (Reg D)5 Nov 2010
  • D<ITEMS>06b

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT5 Nov 2013